References
- RoodmanGDMechanisms of bone metastasisN Engl J Med2004350161655166415084698
- ColemanREMetastatic bone disease: clinical features, pathophysiology and treatment strategiesCancer Treat Rev200127316517611417967
- LiSPengYWeinhandlEDEstimated number of prevalent cases of metastatic bone disease in the US adult populationClin Epidemiol20124879322570568
- ClareCRoyleDSahariaKPainful bone metastases: a prospective observational cohort studyPalliat Med200519752152516295283
- DielIJEffectiveness of bisphosphonates on bone pain and quality of life in breast cancer patients with metastatic bone disease: a reviewSupport Care Cancer200715111243124917393190
- MartinMBellRBourgeoisHBone-related complications and quality of life in advanced breast cancer: results from a randomized phase III trial of denosumab versus zoledronic acidClin Cancer Res201218174841484922893628
- SolomayerEFDielIJMeybergGCGollanCBastertGMetastatic breast cancer: clinical course, prognosis and therapy related to the first site of metastasisBreast Cancer Res Treat200059327127810832597
- von MoosRBodyJJEgerdieBPain and health-related quality of life in patients with advanced solid tumours and bone metastases: integrated results from three randomized, double-blind studies of denosumab and zoledronic acidSupport Care Cancer201321123497350723975226
- SathiakumarNDelzellEMorriseyMAMortality following bone metastasis and skeletal-related events among women with breast cancer: a population-based analysis of US. Medicare beneficiaries, 1999–2006Breast Cancer Res Treat2012131123123821842243
- SaadFLiptonACookRChenYMSmithMColemanRPathologic fractures correlate with reduced survival in patients with malignant bone diseaseCancer200711081860186717763372
- ChawlaNYabroffKRMariottoAMcNeelTSSchragDWarrenJLLimited validity of diagnosis codes in Medicare claims for identifying cancer metastases and inferring stageAnn Epidemiol2014249666672672.e1e225066409
- OnukwughaEYongCHussainASealBMullinsCDConcordance between administrative claims and registry data for identifying metastasis to the bone: an exploratory analysis in prostate cancerBMC Med Res Methodol201414124383436
- HagbergKWTaylorAHernandezRKJickSIncidence of bone metastases in breast cancer patients in the United Kingdom: results of a multi-database linkage study using the general practice research databaseCancer Epidemiol201337324024623416031
- JensenAONorgaardMYongMFryzekJPSorensenHTValidity of the recorded International Classification of Diseases, 10th edition diagnoses codes of bone metastases and skeletal-related events in breast and prostate cancer patients in the Danish National Registry of PatientsClin Epidemiol2009110110820865091
- EhrensteinVHernandezRKMaegbaekMLValidation of algorithms to detect distant metastases in men with prostate cancer using routine registry data in DenmarkClin Epidemiol2015725926525914556
- HowladerNChenVWRiesLAOverview of breast cancer collaborative stage data items – their definitions, quality, usage, and clinical implications: a review of SEER data for 2004–2010Cancer2014120Suppl 233771378025412389
- XGEVA® (denosumab) [package insert]Thousand Oaks, CAAmgen Inc2013
- ScheidVBuzdarAUSmithTLHortobagyiGNClinical course of breast cancer patients with osseous metastasis treated with combination chemotherapyCancer19865812258925933779609
- Early Breast Cancer Trialists’ Collaborative GroupEffects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trialsLancet200536594721687171715894097
- HarriesMTaylorAHolmbergLIncidence of bone metastases and survival after a diagnosis of bone metastases in breast cancer patientsCancer Epidemiol201438442743424923857
- RothmanKGreenlandSLashTModern Epidemiology3rd edPhiladelphia, PALippincott Williams & Wilkins2008